Cynosure Group LLC Sells 618 Shares of Houlihan Lokey, Inc. (NYSE:HLI)

Cynosure Group LLC trimmed its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 21.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,263 shares of the financial services provider’s stock after selling 618 shares during the quarter. Cynosure Group LLC’s holdings in Houlihan Lokey were worth $358,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the business. Lazard Asset Management LLC purchased a new stake in Houlihan Lokey during the first quarter valued at approximately $127,000. Price T Rowe Associates Inc. MD lifted its position in Houlihan Lokey by 6.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 26,709 shares of the financial services provider’s stock worth $3,424,000 after buying an additional 1,631 shares during the last quarter. Janus Henderson Group PLC boosted its stake in Houlihan Lokey by 27.1% during the first quarter. Janus Henderson Group PLC now owns 30,656 shares of the financial services provider’s stock worth $3,927,000 after buying an additional 6,535 shares during the period. Tidal Investments LLC raised its stake in shares of Houlihan Lokey by 201.5% in the first quarter. Tidal Investments LLC now owns 11,093 shares of the financial services provider’s stock valued at $1,422,000 after acquiring an additional 7,414 shares during the period. Finally, Cetera Investment Advisers lifted its holdings in shares of Houlihan Lokey by 604.4% in the 1st quarter. Cetera Investment Advisers now owns 13,525 shares of the financial services provider’s stock worth $1,734,000 after acquiring an additional 11,605 shares during the last quarter. Institutional investors own 78.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. StockNews.com downgraded shares of Houlihan Lokey from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. UBS Group increased their price target on Houlihan Lokey from $170.00 to $190.00 and gave the stock a “buy” rating in a report on Tuesday, October 8th. Wells Fargo & Company started coverage on Houlihan Lokey in a report on Thursday, September 12th. They set an “underweight” rating and a $149.00 price objective for the company. Finally, Morgan Stanley increased their target price on Houlihan Lokey from $146.00 to $163.00 and gave the stock an “equal weight” rating in a research note on Monday, September 23rd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $157.00.

Insider Buying and Selling at Houlihan Lokey

In related news, General Counsel Christopher M. Crain sold 1,000 shares of the company’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total transaction of $155,290.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gillian Beth Zucker sold 200 shares of Houlihan Lokey stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $152.28, for a total value of $30,456.00. Following the completion of the transaction, the director now owns 6,801 shares in the company, valued at $1,035,656.28. This trade represents a 2.86 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,400 shares of company stock valued at $219,362. 23.68% of the stock is currently owned by corporate insiders.

Houlihan Lokey Stock Down 1.4 %

HLI opened at $187.43 on Friday. The stock’s fifty day moving average is $172.26 and its two-hundred day moving average is $152.74. The company has a market capitalization of $13.03 billion, a P/E ratio of 38.33 and a beta of 0.65. Houlihan Lokey, Inc. has a 52 week low of $104.86 and a 52 week high of $192.10.

Houlihan Lokey (NYSE:HLI) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.15. Houlihan Lokey had a net margin of 15.77% and a return on equity of 19.29%. The company had revenue of $574.96 million during the quarter, compared to analyst estimates of $537.93 million. During the same period in the prior year, the firm earned $1.11 earnings per share. The firm’s revenue for the quarter was up 23.1% compared to the same quarter last year. Equities analysts anticipate that Houlihan Lokey, Inc. will post 5.79 earnings per share for the current year.

Houlihan Lokey Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Sunday, December 15th. Shareholders of record on Monday, December 2nd will be issued a dividend of $0.57 per share. The ex-dividend date is Monday, December 2nd. This represents a $2.28 dividend on an annualized basis and a yield of 1.22%. Houlihan Lokey’s dividend payout ratio is currently 46.63%.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.